- Home
- VIR vs EVRI Comparison
VIR vs EVRI Comparison
Compare VIR & EVRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- EVRI
- Stock Information
- Founded
- VIR 2016
- EVRI 1998
- Country
- VIR United States
- EVRI United States
- Employees
- VIR N/A
- EVRI N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- EVRI Services-Misc. Amusement & Recreation
- Sector
- VIR Health Care
- EVRI Consumer Discretionary
- Exchange
- VIR Nasdaq
- EVRI Nasdaq
- Market Cap
- VIR 1.4B
- EVRI 1.2B
- IPO Year
- VIR 2019
- EVRI 2005
- Fundamental
- Price
- VIR $9.70
- EVRI $13.63
- Analyst Decision
- VIR Buy
- EVRI Hold
- Analyst Count
- VIR 6
- EVRI 5
- Target Price
- VIR $34.83
- EVRI $12.88
- AVG Volume (30 Days)
- VIR 3.8M
- EVRI 523.7K
- Earning Date
- VIR 02-20-2025
- EVRI 02-27-2025
- Dividend Yield
- VIR N/A
- EVRI N/A
- EPS Growth
- VIR N/A
- EVRI N/A
- EPS
- VIR N/A
- EVRI 0.15
- Revenue
- VIR $78,618,000.00
- EVRI $760,419,000.00
- Revenue This Year
- VIR N/A
- EVRI N/A
- Revenue Next Year
- VIR N/A
- EVRI $5.06
- P/E Ratio
- VIR N/A
- EVRI $91.20
- Revenue Growth
- VIR N/A
- EVRI N/A
- 52 Week Low
- VIR $6.56
- EVRI $6.37
- 52 Week High
- VIR $14.45
- EVRI $13.65
- Technical
- Relative Strength Index (RSI)
- VIR 52.17
- EVRI 59.59
- Support Level
- VIR $10.09
- EVRI $13.59
- Resistance Level
- VIR $11.39
- EVRI $13.65
- Average True Range (ATR)
- VIR 0.71
- EVRI 0.04
- MACD
- VIR -0.11
- EVRI -0.00
- Stochastic Oscillator
- VIR 16.57
- EVRI 63.64
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About EVRI Everi Holdings Inc.
Everi Holdings Inc provides entertainment and technology solutions for the casino, interactive, and gaming industry. It operates in two segments namely Games and Financial Technology Solutions (FinTech). Enveri Games provides gaming operators with gaming technology products and services which include gaming machines, slot machines, leased gaming equipment, and other products and services. Enveri FinTech provides gaming operators with financial technology products and services which include services and equipment that facilitate casino patron's to access cash at gaming facilities through automated teller machines, point of sale debit card purchases and others.